News
-
-
-
-
PRESS RELEASE
Exasol announces preliminary group results for 2024 – positive EBITDA, net income and cash flow for the first time since IPO
Exasol AG announces positive preliminary group results for 2024, including first-time positive EBITDA, net income, and cash flow since IPO. Continued focus on on-premise and hybrid solutions sectors -
-
-
-
-
-
PRESS RELEASE
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East
Nyxoah announces commercial launch of Genio(R) breakthrough therapy in the Middle East, with first successful implant in Dubai. CEO highlights historic milestone and commitment to transforming OSA treatment globally